Tags

Type your tag names separated by a space and hit enter

Surgical pathological second opinion in thyroid malignancy: impact on patients' management and prognosis.
Eur J Surg Oncol. 2005 Feb; 31(1):74-7.EJ

Abstract

OBJECTIVES

To evaluate the effect of inter-institutional surgical pathology review of thyroid cancer on patients' treatment and prognosis.

METHODS

All cases referred to the Institute of Pathology at Leeds for thyroid pathology review between January 2001 and March 2003 were included. The referring pathologists reports were compared to those produced in the MDT meeting by the expert pathologist. Whenever there was disagreement a third expert opinion was sought who was blinded for both diagnoses. Effects on management and prognosis were evaluated if there was disagreement.

RESULTS

Of the 66 patients reviewed, 12 (18%) had a different pathological diagnosis (kappa=0.33). Two had their diagnosis changed from malignant to benign and a further two from benign to malignant. Eight patients had their prognosis downgraded and four upgraded after histopathological review. Five patients had their management affected by the new pathological diagnosis.

CONCLUSION

A second opinion of surgical pathology for thyroid tumours can result in major therapeutic and prognostic modifications. All cases of suspected thyroid cancers should be reviewed in a multidisciplinary meeting supported by pathologist with experience in thyroid pathology.

Authors+Show Affiliations

Hamady ZZ
Breast and Endocrine Unit, St James's University Hospitals, Beckett Street, Leeds LS9 7TF, UK. zaid_nisreen@yahoo.co.uk
Mather N
No affiliation info available
Lansdown MR
No affiliation info available
Davidson L
No affiliation info available
Maclennan KA
No affiliation info available

MeSH

Diagnostic ErrorsFemaleHumansMaleNeoplasm StagingPathology, SurgicalPrognosisReferral and ConsultationRetrospective StudiesThyroid Neoplasms

Pub Type(s)

Journal Article

Language

eng

PubMed ID

15642429

Citation

Hamady, Z Z R., et al. "Surgical Pathological Second Opinion in Thyroid Malignancy: Impact On Patients' Management and Prognosis." European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, vol. 31, no. 1, 2005, pp. 74-7.
Hamady ZZ, Mather N, Lansdown MR, et al. Surgical pathological second opinion in thyroid malignancy: impact on patients' management and prognosis. Eur J Surg Oncol. 2005;31(1):74-7.
Hamady, Z. Z., Mather, N., Lansdown, M. R., Davidson, L., & Maclennan, K. A. (2005). Surgical pathological second opinion in thyroid malignancy: impact on patients' management and prognosis. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 31(1), 74-7.
Hamady ZZ, et al. Surgical Pathological Second Opinion in Thyroid Malignancy: Impact On Patients' Management and Prognosis. Eur J Surg Oncol. 2005;31(1):74-7. PubMed PMID: 15642429.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Surgical pathological second opinion in thyroid malignancy: impact on patients' management and prognosis. AU - Hamady,Z Z R, AU - Mather,N, AU - Lansdown,M R, AU - Davidson,L, AU - Maclennan,K A, PY - 2004/08/16/accepted PY - 2005/1/12/pubmed PY - 2005/3/11/medline PY - 2005/1/12/entrez SP - 74 EP - 7 JF - European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology JO - Eur J Surg Oncol VL - 31 IS - 1 N2 - OBJECTIVES: To evaluate the effect of inter-institutional surgical pathology review of thyroid cancer on patients' treatment and prognosis. METHODS: All cases referred to the Institute of Pathology at Leeds for thyroid pathology review between January 2001 and March 2003 were included. The referring pathologists reports were compared to those produced in the MDT meeting by the expert pathologist. Whenever there was disagreement a third expert opinion was sought who was blinded for both diagnoses. Effects on management and prognosis were evaluated if there was disagreement. RESULTS: Of the 66 patients reviewed, 12 (18%) had a different pathological diagnosis (kappa=0.33). Two had their diagnosis changed from malignant to benign and a further two from benign to malignant. Eight patients had their prognosis downgraded and four upgraded after histopathological review. Five patients had their management affected by the new pathological diagnosis. CONCLUSION: A second opinion of surgical pathology for thyroid tumours can result in major therapeutic and prognostic modifications. All cases of suspected thyroid cancers should be reviewed in a multidisciplinary meeting supported by pathologist with experience in thyroid pathology. SN - 0748-7983 UR - https://www.unboundmedicine.com/medline/citation/15642429/Surgical_pathological_second_opinion_in_thyroid_malignancy:_impact_on_patients'_management_and_prognosis_ DB - PRIME DP - Unbound Medicine ER -